| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 4 |
| 1 | INFLIXIMAB | 4 |
| 2 | OCTREOTIDE ACETATE | 3 |
| 3 | ALPRAZOLAM | 2 |
| 4 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 2 |
| 5 | ITRACONAZOLE | 2 |
| 6 | OFLOXACIN | 2 |
| 7 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 2 |
| 8 | OFLOXACIN OTIC | 2 |
| 9 | OFLOXACIN OTIC SOLUTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 1 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 2 | 0.0003 |
| 2 | OFLOXACIN OTIC SOLUTION | 2 | 0.0003 |
| 3 | OFLOXACIN OTIC | 2 | 0.0003 |
| 4 | OFLOXACIN | 2 | 0.0003 |
| 5 | SIPULEUCEL-T | 1 | 0.0002 |
| 6 | ITRACONAZOLE | 2 | 0.0002 |
| 7 | C1 ESTERASE INHIBITOR RECOMBINANT | 1 | 0.0002 |
| 8 | REPAGLINIDE | 1 | 0.0001 |
| 9 | OCTREOTIDE ACETATE | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| 1 | Corticosteroid [EPC] | 5 |
| 2 | Aminosalicylate [EPC] | 2 |
| 3 | Azole Antifungal [EPC] | 2 |
| 4 | Benzodiazepine [EPC] | 2 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 6 | Quinolone Antimicrobial [EPC] | 2 |
| 7 | Autologous Cellular Immunotherapy [EPC] | 1 |
| 8 | Calcium Channel Blocker [EPC] | 1 |
| 9 | Catecholamine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 2 | Glinide [EPC] | 1 | 0.0001 |
| 3 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 4 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 5 | Azole Antifungal [EPC] | 2 | 0.0000 |
| 6 | Catecholamine [EPC] | 1 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Parathyroid Hormone Analog [EPC] | 1 | 0.0000 |